These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 9664598

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [Abstract] [Full Text] [Related]

  • 6. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium.
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [Abstract] [Full Text] [Related]

  • 7. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ, Dickinson JE, O'Leary P, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R.
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K.
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes.
    Barrett SL, Bower C, Hadlow NC.
    Prenat Diagn; 2008 Jan; 28(1):28-35. PubMed ID: 18186146
    [Abstract] [Full Text] [Related]

  • 12. Maternal serum free beta-hCG and PAPP-A in patients with habitual abortion-influence on first-trimester screening for chromosomal abnormalities.
    Heinig J, Steinhard J, Schmitz R, Nofer JR, Kiesel L, Klockenbusch W.
    Prenat Diagn; 2007 Sep; 27(9):814-6. PubMed ID: 17554803
    [Abstract] [Full Text] [Related]

  • 13. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [Abstract] [Full Text] [Related]

  • 14. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?
    Goncé A, Borrell A, Fortuny A, Casals E, Martínez MA, Mercadé I, Cararach V, Vanrell JA.
    Prenat Diagn; 2005 Dec; 25(12):1156-61. PubMed ID: 16231401
    [Abstract] [Full Text] [Related]

  • 15. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
    Amor DJ, Xu JX, Halliday JL, Francis I, Healy DL, Breheny S, Baker HW, Jaques AM.
    Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
    [Abstract] [Full Text] [Related]

  • 16. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland.
    Valinen Y, Rapakko K, Kokkonen H, Laitinen P, Tekay A, Ahola T, Ryynanen M.
    Am J Obstet Gynecol; 2007 Mar; 196(3):278.e1-5. PubMed ID: 17346554
    [Abstract] [Full Text] [Related]

  • 17. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
    Ong CY, Lee CP, Leung KY, Lau E, Tang MH.
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
    [Abstract] [Full Text] [Related]

  • 18. First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study.
    Wright D, Spencer K, Nix B.
    Prenat Diagn; 2007 Dec; 27(12):1118-22. PubMed ID: 17960785
    [Abstract] [Full Text] [Related]

  • 19. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM.
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [Abstract] [Full Text] [Related]

  • 20. First-trimester combined screening for Down syndrome: prediction of low birth weight, small for gestational age and pre-term delivery in a cohort of non-selected women.
    Pihl K, Sørensen TL, Nørgaard-Pedersen B, Larsen SO, Nguyen TH, Krebs L, Larsen T, Christiansen M.
    Prenat Diagn; 2008 Mar; 28(3):247-53. PubMed ID: 18302310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.